marketcaparena
Search

    ACTU

    ACTUATE THERAPEUTICS, INC.

    Company overview

    Market capitalization
    $17.68M
    Employees
    12
    Latest publication
    2026-09-29
    About ACTUATE THERAPEUTICS, INC.

    Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States. The company's lead product candidate is elraglusib injection, a glycogen synthase kinase-3 inhibitor that is in Phase 2 trial to treat metastatic pancreatic ductal adenocarcinoma. It also develops elraglusib, which is in Phase 1/2 trial for the treatment of refractory pediatric malignancies, including Ewing sarcoma, as well as neuroblastoma and pediatric leukemias. The company was formerly known as Apotheca Therapeutics, Inc. and changed its name to Actuate Therapeutics, Inc. in October 2015. Actuate Therapeutics, Inc. was incorporated in 2015 and is headquartered in Fort Worth, Texas.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Revenue0USD0USD0USD0USD0USD0USD0USD0USD
    Research Development2,565,244USD2,129,574USD2,177,922USD2,764,805USD3,220,319USD3,685,939USD3,757,102USD4,372,805USD
    Selling General Administrative3,140,712USD2,558,899USD3,294,456USD3,204,072USD3,145,265USD2,873,189USD1,635,801USD1,062,644USD
    Total Operating Expenses5,705,956USD4,687,673USD5,472,378USD5,968,877USD6,365,584USD6,559,128USD5,392,903USD5,435,449USD
    Operating Income-5,705,956USD-4,687,673USD-5,472,378USD-5,968,877USD-6,365,584USD-6,559,128USD-5,392,903USD-5,435,449USD
    Interest Income85,269USD139,582USD69,971USD24,534USD53,623USD118,115USD80,747USD8,645USD
    Interest Expense5,062USD5,062USD5,063USD5,062USD5,063USD5,076USD3,489USD5,076USD
    Net Interest Income80,207USD134,520USD64,908USD19,472USD48,560USD113,039USD77,258USD3,569USD
    Income Before Tax-5,625,749USD-4,553,153USD-5,407,470USD-5,949,405USD-6,317,024USD-6,446,089USD-5,970,961USD-6,572,219USD
    Net Income-5,625,749USD-4,553,953USD-5,407,470USD-5,949,405USD-6,317,024USD-6,446,089USD-5,970,961USD-6,572,219USD
    Net Income From Continuing Ops-5,625,749USD-4,553,953USD-5,407,470USD-5,949,405USD-6,317,024USD-6,446,089USD-5,970,961USD-6,572,219USD
    Ebitda-5,705,956USD-4,687,673USD-5,402,407USD-5,944,343USD-6,311,961USD-6,322,898USD-5,967,472USD-6,567,143USD
    Total Other Income Expense Net80,207USD134,520USD64,908USD19,472USD48,560USD113,039USD-578,058USD-1,136,770USD
    Income Tax Expense—800USD——————
    Ebit———-5,968,877USD-12,731,168USD-6,441,013USD-5,392,903USD-5,435,449USD
    Depreciation And Amortization————6,365,584USD118,115USD-574,569USD-1,131,694USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USD
    Total Revenue0USD0USD0USD0USD
    Research Development10,292,620USD18,676,276USD21,708,332USD16,387,216USD
    Selling General Administrative12,202,692USD6,484,458USD3,265,497USD3,819,591USD
    Total Operating Expenses22,495,312USD25,160,734USD24,973,829USD20,206,807USD
    Operating Income-22,495,312USD-25,160,734USD-24,973,829USD-20,206,807USD
    Interest Income287,710USD222,293USD352,672USD27,027USD
    Interest Expense20,250USD18,717USD43,641USD16,200USD
    Net Interest Income267,460USD203,576USD309,031USD10,827USD
    Income Before Tax-22,227,852USD-27,284,528USD-24,744,620USD-20,159,401USD
    Income Tax Expense800USD800USD——
    Net Income-22,227,852USD-27,285,328USD-24,744,620USD-20,159,401USD
    Net Income From Continuing Ops-22,227,852USD-27,285,328USD-24,744,620USD-20,159,401USD
    Ebitda-22,495,312USD-25,160,734USD-24,428,129USD-20,079,595USD
    Total Other Income Expense Net267,460USD-2,123,794USD229,209USD47,406USD
    Ebit—-27,304,045USD-24,700,979USD-20,143,201USD
    Depreciation And Amortization—2,143,311USD272,850USD63,606USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets5,199,339USD8,911,286USD14,035,910USD17,713,933USD6,968,901USD4,483,039USD9,318,448USD14,262,781USD
    Cash And Equivalents4,425,841USD———————
    Total Current Assets4,747,941USD8,519,448USD13,643,419USD17,444,000USD6,688,559USD4,248,564USD9,207,900USD14,262,781USD
    Other Current Assets322,100USD385,444USD483,996USD519,237USD195,903USD359,159USD566,278USD739,332USD
    Other Non Current Assets451,398USD———————
    Total Liabilities4,210,187USD———————
    Total Current Liabilities3,805,196USD4,721,897USD5,706,916USD6,372,662USD9,200,721USD9,153,954USD8,802,503USD8,497,410USD
    Total Stockholder Equity989,152USD3,784,398USD7,924,003USD10,936,280USD-2,653,704USD-5,087,737USD104,186USD5,358,688USD
    Total Equity Including Noncontrolling Interest989,152USD———————
    Accounts Payable1,076,691USD1,201,393USD1,524,190USD1,245,375USD3,171,015USD2,644,349USD1,921,189USD2,330,005USD
    Common Stock24USD24USD23USD23USD20USD20USD20USD20USD
    Retained Earnings-165,100,085USD-160,233,450USD-154,607,701USD-150,053,000USD-144,646,000USD-138,696,873USD-132,379,000USD-125,933,760USD
    Total Liab—5,126,888USD6,111,907USD6,777,653USD9,622,605USD9,570,776USD9,214,262USD8,904,093USD
    Other Current Liab—3,520,504USD4,182,726USD5,127,287USD6,029,706USD6,509,605USD6,881,314USD6,167,405USD
    Capital Stock—24USD23USD23USD20USD20USD20USD20USD
    Cash—8,134,004USD13,159,423USD16,924,763USD6,492,656USD3,889,405USD8,641,622USD13,523,449USD
    Cash And Short Term Investments—8,134,004USD13,159,423USD16,924,763USD6,492,656USD3,889,405USD8,641,622USD13,523,449USD
    Net Debt—-7,729,013USD-12,754,432USD-16,924,763USD-6,492,656USD-3,889,405USD-8,641,622USD-13,523,449USD
    Short Long Term Debt Total—404,991USD404,991USD—404,991USD—404,991USD404,991USD
    Common Stock Shares Outstanding—23,537,134shares23,245,203shares21,394,965shares19,646,475shares19,497,731shares19,514,684shares19,514,684shares
    Non Current Assets Total—391,838USD392,491USD269,934USD280,342USD234,475USD110,548USD0USD
    Non Current Liabilities Total—404,990USD404,991USD404,991USD421,884USD416,822USD411,759USD406,683USD
    Non Currrent Assets Other—391,838USD392,491USD269,934USD280,342USD234,475USD110,548USD—
    Net Working Capital—3,797,551USD7,936,503USD11,071,338USD-2,512,162USD-4,905,390USD405,397USD5,765,371USD
    Unclassified Equity—164,017,800USD162,531,658USD160,989,234USD141,992,256USD133,609,096USD132,483,146USD131,292,408USD
    Accumulated Other Comprehensive Income———0USD0USD———
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USD
    Total Assets14,035,910USD9,318,448USD2,995,566USD20,483,056USD
    Other Current Assets483,996USD566,278USD36,907USD33,746USD
    Total Liab6,111,907USD9,214,262USD102,622,079USD5,650,737USD
    Total Stockholder Equity7,924,003USD104,186USD-99,626,513USD14,832,319USD
    Other Current Liab4,182,726USD6,881,314USD3,498,754USD2,214,135USD
    Common Stock23USD20USD2USD3USD
    Capital Stock23USD20USD2USD2USD
    Retained Earnings-154,607,701USD-132,379,000USD-105,094,521USD-80,349,901USD
    Cash13,159,423USD8,641,622USD2,958,659USD20,449,310USD
    Cash And Short Term Investments13,159,423USD8,641,622USD2,958,659USD20,449,310USD
    Total Current Assets13,643,419USD9,207,900USD2,995,566USD20,483,056USD
    Total Current Liabilities5,706,916USD8,802,503USD6,920,594USD4,344,982USD
    Net Debt-12,754,432USD-8,641,622USD-2,958,659USD-20,044,319USD
    Short Long Term Debt Total404,991USD404,991USD—404,991USD
    Accounts Payable1,524,190USD1,921,189USD3,421,840USD2,130,847USD
    Common Stock Shares Outstanding21,021,817shares19,514,684shares15,033,731shares15,033,731shares
    Non Current Assets Total392,491USD110,548USD0USD0USD
    Non Current Liabilities Total404,991USD411,759USD95,701,485USD1,305,755USD
    Non Currrent Assets Other392,491USD110,548USD——
    Net Working Capital7,936,503USD405,397USD-3,925,028USD16,138,074USD
    Unclassified Equity162,531,658USD132,483,146USD5,468,004USD95,182,215USD
    Accumulated Other Comprehensive Income——0USD—
    Unclassified Non Current Liabilities——95,701,485USD1,305,755USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Stock Based Compensation2,697,158USD
    Change To Liabilities-473,399USD
    Change In Working Capital-674,962USD
    Operating Cash Flow-9,422,450USD
    Net Common Stock Issuance-527,716USD
    Unclassified Financing Cash Flow1,216,584USD
    Financing Cash Flow688,868USD
    Change In Cash-8,733,582USD
    End Cash Flow4,425,841USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-5,625,749USD-4,553,953USD-5,407,470USD-5,949,405USD-6,317,024USD-6,446,089USD-5,970,961USD-6,572,219USD
    Stock Based Compensation1,356,389USD1,541,675USD1,800,614USD1,579,271USD1,125,101USD1,191,587USD565,981USD90,019USD
    Other Non Cash Items143,562USD5,062USD5,063USD1,409,107USD5,063USD5,076USD658,729USD1,145,415USD
    Change In Working Capital-891,529USD-728,827USD-3,075,916USD191,311USD568,120USD477,011USD-4,402,762USD2,663,147USD
    Total Cash From Operating Activities-5,017,327USD-3,736,043USD-6,677,709USD-4,348,987USD-4,618,740USD-4,772,415USD-9,149,013USD-2,673,638USD
    Capital Expenditures-3USD-3USD-3USD-3USD0USD-5USD-3USD0USD
    Free Cash Flow-5,017,327USD-3,736,043USD-6,677,709USD-4,348,990USD-4,618,740USD-4,772,410USD-9,149,013USD-2,673,638USD
    Total Cash From Financing Activities-8,092USD-29,297USD17,109,816USD6,952,238USD-133,477USD-109,412USD22,320,753USD957,040USD
    Issuance Of Capital Stock519,624USD0USD17,208,118USD6,784,646USD0USD0USD23,956,800USD0USD
    Change In Cash-5,025,419USD-3,765,340USD10,432,107USD2,603,251USD-4,752,217USD-4,881,827USD13,171,740USD-1,716,598USD
    Begin Period Cash Flow13,159,423USD16,924,763USD6,492,656USD3,889,405USD8,641,622USD13,523,449USD351,709USD2,068,307USD
    End Period Cash Flow8,134,004USD13,159,423USD16,924,763USD6,492,656USD3,889,405USD8,641,622USD13,523,449USD351,709USD
    Other Cashflows From Financing Activities-527,716USD-29,297USD-98,302USD-175,226USD-133,477USD5,500,000USD-1,636,047USD-42,960USD
    Net Borrowings—0USD0USD0USD0USD0USD0USD—
    Unclassified Operating Cash Flow———-1,579,271USD————
    Unclassified Financing Cash Flow—————-5,609,412USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USD
    Net Income-22,227,852USD-27,285,328USD-24,744,620USD-20,159,400USD
    Stock Based Compensation6,046,661USD1,995,793USD423,539USD654,066USD
    Other Non Cash Items20,250USD2,346,811USD123,463USD-20,380USD
    Change In Working Capital-3,045,312USD1,100,076USD2,572,451USD1,731,621USD
    Total Cash From Operating Activities-19,206,253USD-21,842,648USD-21,625,167USD-17,794,093USD
    Capital Expenditures0USD0USD0USD0USD
    Free Cash Flow-19,206,253USD-21,842,648USD-21,625,167USD-17,794,093USD
    Net Borrowings0USD5,500,000USD0USD—
    Total Cash From Financing Activities23,724,054USD27,525,611USD4,134,516USD19,255,569USD
    Issuance Of Capital Stock23,992,764USD23,956,800USD4,134,516USD19,255,569USD
    Change In Cash4,517,801USD5,682,963USD-17,490,651USD1,461,476USD
    Begin Period Cash Flow8,641,622USD2,958,659USD20,449,310USD18,987,834USD
    End Period Cash Flow13,159,423USD8,641,622USD2,958,659USD20,449,310USD
    Other Cashflows From Financing Activities-302,825USD-1,931,189USD4,134,516USD19,255,569USD
    Sale Purchase Of Stock—485,172USD——
    Unclassified Financing Cash Flow—23,471,628USD-4,134,516USD-19,255,569USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    No revenue breakdown is currently published for this company.

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.